Celecoxib PCD Pharma Franchise Company
Cafoli Lifecare offers a Celecoxib range of 2 capsule formulations, manufactured in WHO-GMP certified facilities. Distributors serving orthopaedic, rheumatology and pain-management prescribers can secure district-wise monopoly franchise rights for this COX-2 selective NSAID with full promotional support.
What is Celecoxib?
Celecoxib is a selective cyclo-oxygenase-2 (COX-2) inhibitor NSAID. By preferentially blocking COX-2 it provides anti-inflammatory and analgesic effect with a lower risk of gastric irritation than traditional non-selective NSAIDs, making it suitable for longer-term arthritis therapy. Reference: PubChem - Celecoxib.
Available Forms
The Cafoli Celecoxib portfolio is offered as oral Capsules, including combinations for chronic joint pain. Contact us for current pack presentations and combinations.
Therapeutic Applications
Celecoxib is prescribed for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain and painful musculoskeletal conditions. Prescribers include orthopaedic surgeons, rheumatologists, pain specialists and physicians.
Why Celecoxib is a High-Potential Molecule for Distributors
Arthritis and chronic joint pain affect a huge, ageing population, and celecoxib is preferred for long-term use because its gastric-sparing profile lets patients stay on therapy longer than conventional NSAIDs. That extended-course prescribing across ortho and rheumatology practice gives distributors dependable, high-repeat pain-management volume with better margins than generic NSAIDs.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.
References
- PubChem: Celecoxib
- MedlinePlus: Celecoxib
- PubMed: celecoxib in osteoarthritis
Our formulations of Celecoxib find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: